SLC25A16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.892400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.676400E-01
Normal-vs-Stage2
9.648600E-01
Normal-vs-Stage3
8.123400E-01
Normal-vs-Stage4
6.297800E-01
Stage1-vs-Stage2
3.738600E-01
Stage1-vs-Stage3
5.321800E-01
Stage1-vs-Stage4
4.348000E-01
Stage2-vs-Stage3
6.885000E-01
Stage2-vs-Stage4
5.341000E-01
Stage3-vs-Stage4
8.863800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.808600E-01
Normal-vs-AfricanAmerican
6.308600E-01
Normal-vs-Asian
6.501000E-01
Caucasian-vs-AfricanAmerican
4.536600E-01
Caucasian-vs-Asian
5.073400E-01
AfricanAmerican-vs-Asian
7.891000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.834000E-01
Normal-vs-Female
9.783600E-01
Male-vs-Female
9.799800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.967000E-01
Normal-vs-Age(41-60Yrs)
8.166000E-01
Normal-vs-Age(61-80Yrs)
9.134000E-01
Normal-vs-Age(81-100Yrs)
7.554400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.058000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.842400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.164600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.503400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.030400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.403600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.644200E-01
Normal-vs-Daily Drinker
4.121600E-01
Normal-vs-Weekly Drinker
5.578000E-01
Normal-vs-Occasional Drinker
9.458800E-01
Normal-vs-Social Drinker
7.902600E-01
Non Drinker-vs-Daily Drinker
9.130400E-02
Non Drinker-vs-Weekly Drinker
2.609600E-01
Non Drinker-vs-Occasional Drinker
9.601000E-01
Non Drinker-vs-Social Drinker
5.845400E-01
Daily Drinker-vs-Weekly Drinker
4.358200E-02
Daily Drinker-vs-Occasional Drinker
1.199790E-01
Daily Drinker-vs-Social Drinker
1.227590E-01
Weekly Drinker-vs-Occasional Drinker
2.690800E-01
Weekly Drinker-vs-Social Drinker
5.618600E-01
Occasional Drinker-vs-Social Drinker
6.626200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.280040E-01
Normal-vs-Grade 2
2.031800E-02
Normal-vs-Grade 3
8.447900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.136570E-01
Grade 1-vs-Grade 3
1.864800E-01
Grade 1-vs-Grade 4
1.280040E-01
Grade 2-vs-Grade 3
8.048600E-01
Grade 2-vs-Grade 4
2.031800E-02
Grade 3-vs-Grade 4
8.447900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.583000E-01
Normal-vs-NonDiabetic
9.745200E-01
Diabetic-vs-NonDiabetic
4.867000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.895000E-01
Normal-vs-NoPancreatitis
9.979200E-01
Pancreatitis-vs-NoPancreatitis
8.540200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.202200E-01
Normal-vs-N1
9.410800E-01
N0-vs-N1
2.745800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.169000E-01
Normal-vs-TP53-NonMutant
7.789000E-01
TP53-Mutant-vs-TP53-NonMutant
6.293400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
